Cargando…
Dynamics of clusterin protein expression in the brain and plasma following experimental traumatic brain injury
Progress in the preclinical and clinical development of neuroprotective and antiepileptogenic treatments for traumatic brain injury (TBI) necessitates the discovery of prognostic biomarkers for post-injury outcome. Our previous mRNA-seq data revealed a 1.8–2.5 fold increase in clusterin mRNA express...
Autores principales: | Das Gupta, Shalini, Lipponen, Anssi, Paldanius, Kaisa M. A., Puhakka, Noora, Pitkänen, Asla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934775/ https://www.ncbi.nlm.nih.gov/pubmed/31882899 http://dx.doi.org/10.1038/s41598-019-56683-6 |
Ejemplares similares
-
Analysis of Post-Traumatic Brain Injury Gene Expression Signature Reveals Tubulins, Nfe2l2, Nfkb, Cd44, and S100a4 as Treatment Targets
por: Lipponen, Anssi, et al.
Publicado: (2016) -
Targeting Oxidative Stress with Antioxidant Duotherapy after Experimental Traumatic Brain Injury
por: Kyyriäinen, Jenni, et al.
Publicado: (2021) -
Proteomics of Deep Cervical Lymph Nodes After Experimental Traumatic Brain Injury
por: Puhakka, Noora, et al.
Publicado: (2023) -
Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury
por: Das Gupta, Shalini, et al.
Publicado: (2021) -
Treatment of Status Epilepticus after Traumatic Brain Injury Using an Antiseizure Drug Combined with a Tissue Recovery Enhancer Revealed by Systems Biology
por: Kajevu, Natallie, et al.
Publicado: (2023)